Follows adults with mild obesity and type 2 diabetes over time without surgery
Observes the natural course of type 2 diabetes in adults with mild obesity.
Plain-language title generated from the registry record
Registry title: Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
Key facts
- Where
- Taoyuan City, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 67 years old?
Source: NCT02166372, who can take part
Where in Taiwan
- Min-Sheng General HospitalTaoyuan City, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Min-Sheng General Hospital
- Trial code
- NCT02166372
- Record updated
- 18 June 2014
- Original description
T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.Read full original descriptionShow less
Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.
The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.
Inclusion: Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months; BMI over 25; age between 20 and 67.
Exclusion: Diagnosed with cancer within past five years; HIV positive; Cushing's syndrome; History of organ transplant; History of bariatric surgery; History of alcohol or drug dependency in past five years; serum cretinine over 2.0 mg/dl; Active TB patients; CV events in past six months; C-peptide bellow 1.0 ng/ml in past three months; Diabetic retinopathy; vision bellow 0.1; Psychological problems likely to interfere with adherence to protocol.